CLL-769: Efficacy and Safety of Zanubrutinib in a Fit Subgroup of Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL): Post Hoc Analyses From the SEQUOIA StudyMazyar Shadman, Talha Munir, Danielle M. Brander et al.|Clinical Lymphoma Myeloma & Leukemia|2025Cited by 1